Your session is about to expire
← Back to Search
Tele-HCV for Hepatitis C
N/A
Waitlist Available
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 weeks post treatment
Awards & highlights
Study Summary
This trial is testing whether a peer-facilitated telemedicine treatment plan is more effective than a local referral plan in achieving HCV sustained viral response.
Eligible Conditions
- Hepatitis C
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 36 weeks post treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 weeks post treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Viral Response
Secondary outcome measures
Engagement in harm reduction resources
Treatment Completion
Treatment Initiation
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Tele-HCV TreatmentExperimental Treatment1 Intervention
Participants allocated to telemedicine intervention arm are scheduled for treatment assessment by a study clinician. For a majority of participants, this will also be the treatment initiation visit. If additional studies are necessary for routine treatment decision making, peers will assist participants in navigating health system barriers and arrangement of second telemedicine visit.
Group II: Community Linkage to CareActive Control1 Intervention
Participants allocated to the community linkage-to-care arm will complete screening, be offered enrollment, and undergo informed consent as in the telemedicine arm. Following study inclusion and enrollment, research staff will refer the participant to a local community health clinic to engage in hepatitis C care and seek treatment.
Find a Location
Who is running the clinical trial?
Central City ConcernUNKNOWN
HIV AllianceUNKNOWN
Comagine HealthUNKNOWN
2 Previous Clinical Trials
2,250 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have swelling in your belly or legs.You are currently pregnant or breastfeeding.You have used drugs by injecting them or using non-injection forms of opioids for recreational purposes in the past 90 days.
Research Study Groups:
This trial has the following groups:- Group 1: Community Linkage to Care
- Group 2: Tele-HCV Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
Oregon
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger